G
Giovanni B. Frisoni
Researcher at University of Geneva
Publications - 956
Citations - 55940
Giovanni B. Frisoni is an academic researcher from University of Geneva. The author has contributed to research in topics: Dementia & Medicine. The author has an hindex of 101, co-authored 871 publications receiving 46199 citations. Previous affiliations of Giovanni B. Frisoni include Geneva College & University of Rome Tor Vergata.
Papers
More filters
Journal ArticleDOI
Appraisal of the utility of the amyloid imaging taskforce recommendations for amyloid-PET prescription
Marina Boccardi,Daniele Altomare,Ugo Paolo Guerra,Michela Pievani,Emiliano Albanese,Cristina Festari,Patrizio Pasqualetti,Cristina Muscio,Flavio Nobili,Alessandro Padovani,Giovanni B. Frisoni,Giovanni B. Frisoni +11 more
Journal ArticleDOI
Ic‐p‐006: the incremental value of amyloid pet versus csf biomarkers for the diagnosis of alzheimer's disease (india–fbb study)
Matteo Cotta Ramusino,Daniele Altomare,Frédéric Assal,Aline Mendes,Alfredo Costa,Silvia Morbelli,Matteo Bauckneht,Agnese Picco,Massimo E. Dottorini,Lucia Farotti,Davide V. Moretti,Giordano Savelli,Anna Tarallo,Lucilla Parnetti,Flavio Nobili,Maura Parapini,Elena Salvatore,Marco Salvatore,Marina Boccardi,Giovanni B. Frisoni +19 more
TL;DR: This research presents a novel probabilistic approach to Alzheimer's disease that combines cell reprograming, using a “spatially aggregating” approach, which combines “cell-based” and “dynamic” approaches.
Journal ArticleDOI
Alzheimer’s disease biomarker roadmap 2020: Second‐generation tau PET tracers: Strategic roadmap for the translation of tau biomarkers in the clinic: An international task force
Gérard N. Bischof,Alessandra Dodich,Nicholas J. Ashton,Marina Boccardi,Henryk Barthel,Maria C. Carrillo,Konstantinos Chiotis,Julie Corre,Jean-François Démonet,Anton F. Gietl,Keith A. Johnson,Oskar Hansson,Antoine Leuzy,Marco Lorenzi,Agneta Nordberg,Rik Ossenkoppele,Gil D. Rabinovici,Osman Ratib,Osama Sabri,Valerie Treyer,Paul G. Unschuld,Victor L. Villemagne,Emma E. Wolters,Bengt Winblad,Giovanni B. Frisoni,Valentina Garibotto,Alexander Drzezga +26 more
TL;DR: How second‐generation tau tracers of the second generation may be better suitable for clinical practice was assessed in the context of the Geneva Biomarker Roadmap Initiative during and prior to a two‐day workshop.
Journal Article
The added value of neuroimaging for diagnosing dementia.
TL;DR: The added value of neuroimaging in the dementia workup is unclear, and studies of its cost-effectiveness are lacking.
Journal ArticleDOI
The Italian Alzheimer's Disease Neuroimaging Initiative (IADNI)
Enrica Cavedo,Claudio Babiloni,Alberto Redolfi,Roberta Lizio,Luisa Chiapparini,Umberto Sabatini,Andrea Soricelli,Fabrizio Vernieri,Elena Sinforiani,Gioacchino Tedeschi,Silvia Marino,Maria Grazia Bruzzone,Domenico Acquino,Marcella Alesiani,Andrea Cherubini,Elena Salvatore,Francesco Angeloni,Federica Scrascia,Patrizia Chiarati,Paolo Vitali,Patrizia Montella,Daniele Corbo,Annalisa Baglieri,Placido Bramanti,Filippo Carducci,Carlo Cosimo Quattrocchi,Giovanni B. Frisoni +26 more
TL;DR: Preliminary findings from the two study cohorts suggest the Abeta42 and hippocampal measurements may be used in combination to which MCI patients do or do not progress to AD over 26-36 months with the greatest accuracy.